Vera Therapeutics, Inc. VERA
32.54
(0.80)
(2.40%)
as of 25 Sep
- Market cap
- $2.4B
- P/E
- 0.0×
Follow VERA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (91.75%) | (71.32%) | (50.71%) | (73.25%) |
+8 more TTM periods Free account |
|
| (72.32%) | (59.90%) | (43.10%) | (56.87%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(83.87%) | (64.65%) | (44.27%) | (53.54%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(4.72) | (4.11) | (3.76) | (3.31) | |
Free Cash Flow |
(338.91) | (293.66) | (241.73) | (211.46) | |
Capital Expenditures |
(0.26) | (0.47) | (0.63) | (1.17) | |
| Other line items | |||||
Cash ROIC |
(34.48%) | (25.03%) | (17.30%) | (21.66%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.84 | 0.79 | 0.80 | 0.83 | |
Depreciation/Fixed assets |
0.00 | 0.00 | (3.39) | (5.29) | |
Capex/Depreciation |
0.22 | 0.19 | 0.14 | 0.19 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(4.71) | (4.10) | (3.75) | (3.29) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.02) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates